Stay updated on Daratumumab in Untreated Myeloma: Transplant Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in Untreated Myeloma: Transplant Clinical Trial page.

Latest updates to the Daratumumab in Untreated Myeloma: Transplant Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check34 days agoNo Change Detected
- Check41 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check48 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check63 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check70 days agoChange DetectedThe website has updated the intervention details to include a verified status from December 2020 and has revised to version 2.14.0, while the previous version 2.13.3 and its intervention type have been removed.SummaryDifference3%
- Check99 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
Stay in the know with updates to Daratumumab in Untreated Myeloma: Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in Untreated Myeloma: Transplant Clinical Trial page.